Harvard Bioscience (HBIO) Misses Q3 EPS by 2c

Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $25.7 million versus the consensus estimate of $27.01 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Harvard Bioscience (HBIO) PT Raised to $7.50 at Benchmark on Q2 Beat and Raise
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c